Venlafaxine- and trazodone-induced serotonin syndrome [5]

American Journal of Psychiatry

Volumn 158, Issue 12, 2001, Pages 2088-2089

  McCue, R E ^a   Joseph, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOCUSATE SODIUM; METHADONE; MIRTAZAPINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE;

ADULT; CASE REPORT; CONSTIPATION; DEPRESSION; DRUG INDUCED DISEASE; HUMAN; INSOMNIA; LETTER; MALE; MENTAL DISEASE; METHADONE TREATMENT; OPIATE ADDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SEROTONIN SYNDROME; SUSTAINED RELEASE PREPARATION;

CYCLOHEXANOLS; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; SEROTONIN SYNDROME; TRAZODONE;

EID: 0035180381     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.12.2088     Document Type: Letter

References (4)

1. The serotonin syndrome
2. Serotonin syndrome produced by a combination of fluoxetine and lithium
3. Serotonin syndrome produced by paroxetine and low-dose trazodone
4. Methadone increases mouse brain 5-hydroxyindoleacetic acid